Compare Andalan Perkasa Abadi Tbk. (NASA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Andalan Perkasa Abadi Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Andalan Perkasa Abadi Tbk. trades at Rp34 (market cap 407.18B, 759K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Andalan Perkasa Abadi Tbk. is far larger — about 3.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| NASA | SCPI | |
|---|---|---|
Market Cap | 407.18B | 104.4B |
Volume | 759K | — |
Lot | 7.59K | — |
Turnover | 26.26M | — |
Average Price | 34.59 | — |
Value | 26.26M | — |
Indicative Equilibrium Price | 34 | — |
Indicative Equilibrium Volume | 388 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Andalan Perkasa Abadi Tbk.
PT Ayana Land International Tbk (the Company) was established under the name of PT Gatra Wibawa Sejati Based on Deed No. 157 dated February 27, 2014 of Humberg Lie, S.H., S.E., M.Kn., Notaryin Jakarta.
Read more on NASA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
